Amazon Pharmacy to offer new Ozempic pill

 Amazon Pharmacy will start offering Novo Nordisk's Ozempic pill for same-day delivery and pickup through kiosks.

The pill is the only FDA-approved oral GLP-1 medication used to treat type 2 diabetes, controlling blood sugar in patients. Those with a prescription can check availability, prices, and order through Amazon Pharmacy. The lowest price with insurance starts at $25 per month, and $149 for cash-paying customers. The delivery can be received at the doorstep or in an in-office kiosk.

"Amazon Pharmacy continues to provide customers expanded selection and reliable, convenient access to the latest treatments like the Ozempic pill for type 2 diabetes, helping reduce the friction that comes with accessing breakthrough medications," said Vice President and General Manager of Amazon Pharmacy, Tanvi Patel.

https://breakingthenews.net/Article/Amazon-Pharmacy-to-offer-new-Ozempic-pill/66243140

'Zelensky: Russia not serious about ceasefire'

 Ukrainian President Volodymyr Zelensky remarked on Thursday that Russia's recent armed actions against his country show that it is "not seriously considering a ceasefire."

"Ukraine will act justly – day by day. We proposed a ceasefire starting at midnight on May 6. Yesterday and today, Russia has violated this ceasefire regime. In a mirror response to Russian strikes, we will continue our long-range sanctions," Zelensky wrote on his social media accounts, while noting Kiev's dedication to solving the crisis diplomatically.

Zelensky added that Ukraine's long-range sanctions "have once again reached Perm, which is more than 1,500 kilometers from our border." He stressed that his country will continue to target Russia's military-industrial complex if Moscow does not end its military campaign.

https://breakingthenews.net/Article/Zelensky:-Russia-not-serious-about-ceasefire/66242771

Saudi TV: Hormuz transit breakthrough within hours

 A "breakthrough" to restart movement for stranded ships through the Strait of Hormuz is "expected in the coming hours," Saudi Arabia's state-owned and operated Al-Hadath television channel reported on Thursday.

"A breakthrough regarding the ships stranded in the Strait is expected in the coming hours," the outlet predicted. "Agreements have reportedly been reached regarding easing the blockade in exchange for a gradual reopening of the Strait."

The chokepoint is vital for Gulf energy exports, including from Saudi Arabia, which was also targeted during the recent Iran conflict. The strait has been largely closed since February, blocking roughly 25% of global seaborne oil and forcing costly route changes.

https://breakingthenews.net/Article/Saudi-TV:-Hormuz-transit-breakthrough-within-hours/66243431

China reports first oil tanker targeted in Hormuz

 A Chinese oil tanker was attacked in the Strait of Hormuz on Tuesday, May 4, Chinese media outlet Caixin Global reported on Thursday. The event marks the first instance of a China-owned vessel being targeted in the embattled maritime chokepoint.

Iranian Foreign Minister Abbas Araghchi met his Chinese counterpart Wang Yi in Beijing on Wednesday for talks, marking his first visit to the Asian giant.

Earlier this week, the San Antonio, a container ship of the world's third-largest container shipping line, CMA CGM, was attacked while transiting ‌the vital waterway, injuring crew members and damaging the vessel.

https://breakingthenews.net/Article/China-reports-first-oil-tanker-targeted-in-Hormuz/66240838

China sentences ex-ministers to suspended death

 China sentenced former defense ministers ​Wei Fenghe and ‌Li Shangfu to ​death with ​a two-year reprieve on corruption charges, state ​media Xinhua reported ​on Thursday.

In 2024, the two men were expelled from the ruling Communist Party for "serious violations of discipline," which is a euphemism for corruption. In China, a death sentence with reprieve is usually converted to life in prison if the defendant does not commit any crimes during the reprieve time.

Li was found guilty by disciplinary bodies of "serious violation" of organizational and political discipline, including taking "huge sums of money and valuables in return" for favors. Li's predecessor as defense minister, Wei Fenghe, was also dismissed for graft-related offences.

https://breakingthenews.net/Article/China-sentences-ex-ministers-to-suspended-death/66242185

Alcon revenue miss, ups EPS growth guidance

 

Alcon reports Q1 2026 results with non-GAAP EPS $0.85 (+16% YoY) beating estimates and revenue $2.7B (+10% YoY) missing estimates

• Raises 2026 core EPS growth guidance to 10–13% from 9–12%.
• Authorizes up to $1.5 billion share repurchase program in aggregate.

https://finviz.com/quote?t=ALC&p=d#google_vignette

Nerve stimulation device maker Mobia Medical sets terms for $150 million IPO, pricing this week

 Mobia Medical, which sells a nerve stimulation device for chronic ischemic stroke, announced terms for its IPO on Monday.

The Austin, TX-based company plans to raise $150 million by offering 10 million shares at a price range of $14 to $16.

Mobia's Vivistim Paired Vagus Nerve Stimulation System is the first and only clinically-validated, FDA-approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairments. The system includes an implanted pulse generator and lead that deliver stimulation during functional movement in order to increase neuroplasticity and durably restore motor function. Management estimates that there are over four million chronic ischemic stroke survivors, of which one million have the health, cognition, and motivation to participate in post-stroke therapy, representing a $30 billion opportunity based on the system's price.

Mobia Medical was founded in 2007 and booked $32 million in revenue for the 12 months ended December 31, 2025. It plans to list on the Nasdaq under the symbol MOBI. BofA Securities, J.P. Morgan, and Goldman Sachs are the joint bookrunners on the deal. It is expected to price the week of May 4, 2026.

Relevant Profile: MOBI

https://www.renaissancecapital.com/IPO-Center/News/118736/Nerve-stimulation-device-maker-Mobia-Medical-sets-terms-for-$150-million-IP